Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
about
Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vectorIn vivo reversion to normal of inherited mutations in humans.Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning.Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
P2860
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@en
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@nl
type
label
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@en
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@nl
prefLabel
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@en
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@nl
P2093
P2860
P356
P1476
Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
@en
P2093
Hanazono Y
Koremoto M
Mizukami H
Sugamura K
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703613
P407
P577
2002-07-01T00:00:00Z
P5875
P6179
1039110524